Answers are grounded in this paper and cite their sources.
Novel tricuspid valve replacement technique improves outcomes in patients with severe regurgitation, suggesting potential for wider use.
OBJECTIVES When tricuspid valve repair is unfeasible due to extensive damage or a complex congenital malformation, surgeons consider tricuspid valve replacement (TVR). However, it is still controversial and challenging to choose the best substitute. We aimed to introduce the innovative intra-operatively valve construction using the native right atrial appendage (RAA) tissue for TVR and investigate the short-term outcomes. METHODS This study recruited paediatric and adult patients with unrepairable severe tricuspid regurgitation (TR) who needed TVR. The patient’s right atrial appendage tissue was harvested and used to reconstruct a native bileaflet valve during surgery. Trans-thoracic echocardiography was conducted before operation, 6, and 12 months after surgery. RESULTS The procedure was successfully executed on three patients with valve destruction as a result of infective endocarditis (IE), and three patients who had severe TR due to congenital anomalies. There was no mortality or related morbidity. All the constructed valves had proper function with no complications after the surgery. Follow-up echocardiographic studies showed stable and satisfactory valve function with no regurgitation or significant stenosis. CONCLUSIONS The novel tricuspid valve operation using native RAA tissue demonstrates promising short-term results. Further studies with larger cohorts and longer follow-ups are required to confirm the technique’s reliability and long-term effectiveness.
No takes yet. Share an insight, caveat, or question.
Amirghofran et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: